Back to User profile » Professor Rassoul Dinarvand

Papers published by Professor Rassoul Dinarvand:


Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]

Yousefpour P, Atyabi F, Vasheghani-Farahani E, Movahedi M, Dinarvand R

International Journal of Nanomedicine 2022, 17:5047-5048

Published Date: 26 October 2022

Burgeoning Polymer Nano Blends for Improved Controlled Drug Release: A Review

Maghsoudi S, Taghavi Shahraki B, Rabiee N, Fatahi Y, Dinarvand R, Tavakolizadeh M, Ahmadi S, Rabiee M, Bagherzadeh M, Pourjavadi A, Farhadnejad H, Tahriri M, Webster TJ, Tayebi L

International Journal of Nanomedicine 2020, 15:4363-4392

Published Date: 19 June 2020

Cationic graphene oxide nanoplatform mediates miR-101 delivery to promote apoptosis by regulating autophagy and stress

Assali A, Akhavan O, Mottaghitalab F, Adeli M, Dinarvand R, Razzazan S, Arefian E, Soleimani M, Atyabi F

International Journal of Nanomedicine 2018, 13:5865-5886

Published Date: 1 October 2018

Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study

Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN

International Journal of Nanomedicine 2012, 7:1851-1863

Published Date: 11 April 2012

Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method

Jafarzadeh Kashi TS, Eskandarion S, Esfandyari-Manesh M, Amin Marashi SM, Samadi N, Fatemi SM, Atyabi F, Eshraghi S, Dinarvand R

International Journal of Nanomedicine 2012, 7:221-234

Published Date: 10 January 2012

Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab

Yousefpour P, Atyabi F, Vasheghani-Farahani E, Mousavi Movahedi AA, Dinarvand R

International Journal of Nanomedicine 2011, 6:1977-1990

Published Date: 14 September 2011

Docetaxel immunonanocarriers as targeted delivery systems for HER2-positive tumor cells: preparation, characterization, and cytotoxicity studies

Noori Koopaei M, Dinarvand R, Amini M, Rabbani H, Emami S, Ostad SN, Atyabi F

International Journal of Nanomedicine 2011, 6:1903-1912

Published Date: 8 September 2011

Use of biotin targeted methotrexate–human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy

Taheri A, Dinarvand R, Salman Nouri F, Khorramizadeh MR, Taheri Borougeni A, Mansoori P, Atyabi F

International Journal of Nanomedicine 2011, 6:1863-1874

Published Date: 8 September 2011

Poly (ε-caprolactone) nanofibrous ring surrounding a polyvinyl alcohol hydrogel for the development of a biocompatible two-part artificial cornea

Bakhshandeh H, Soleimani M, Shah Hosseini S, Hashemi H, Shabani I, Shafiee A, Behesht Nejad AH, Erfan M, Dinarvand R, Atyabi F

International Journal of Nanomedicine 2011, 6:1509-1515

Published Date: 14 July 2011

Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations

Yousefpour P, Atyabi F, Vasheghani Farahani E, Sakhtianchi R, Dinarvand R

International Journal of Nanomedicine 2011, 6:1487-1496

Published Date: 11 July 2011

Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents

Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F

International Journal of Nanomedicine 2011, 6:877-895

Published Date: 27 April 2011

Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube

Sobhani Z, Dinarvand R, Atyabi F, Ghahremani M, Adeli M

International Journal of Nanomedicine 2011, 6:705-719

Published Date: 5 April 2011